glp-1 news today 2025 How Employers Can Manage Costs in Their Health Plans GLP-1s and AI tools: 2025's

Antiamyloid therapies have recently changed the treatment landscape

Dietary supplements like Kourtney Kardashians Lemme GLP-1 Daily have hit the market recently, but experts say these supplements lack the data and evidence needed to support their weight loss claims.

Preclinical and initial human studies suggest that glucagon-like peptide-1 receptor agonists may be promising treatments for alcohol use disorder, but existing approved treatments should be used until safety and efficacy is demonstrated in clinical trials.

Recent research suggests that semaglutide, a medication primarily used for type 2 diabetes and weight management, may also help reduce alcohol consumption

Learn what happens after GLP-1 weight loss, including maintenance planning, muscle preservation, weight regain risk, dose review, and long-term metabolic health.

GLP-1 receptor agonists trace their roots back to exendin-4, a peptide isolated from Gila monster venom in the early 1990san insight that eventually led to exenatide and reshaped the treatment of diabetes and metabolic disease